To assess whether discharging patients early after radical cystectomy (RC) is associated with an increased risk of readmission and post-discharge complications.
Introduction
In the current healthcare environment, medical centres are consistently challenged to provide both high-quality and costeffective surgical care. Reducing postoperative length of hospital stay (LOS) with safe and efficient peri-operative care pathways is a potential strategy to improve healthcare cost utilization. Across surgical specialties, studies have shown a clear trend towards shorter LOS in recent years [1] [2] [3] [4] ; however, there is still a concern that excessive postoperative LOS reduction may result in increased risk of post-discharge adverse events, including readmissions and post-discharge complications [5] . A growing body of literature on this concept exists in the fields of general, cardiovascular and orthopaedic surgeries [6] [7] [8] [9] [10] [11] ; however, the data on early discharge after major urological surgery remains limited [12] .
Radical cystectomy (RC) with urinary diversion is a complex operation associated with significant morbidity profiles, such as high complication rates, long hospital stays, and high readmission rates [13, 14] . With improvements in surgical techniques, peri-operative care, and defined postoperative pathways, early discharge after RC may become possible [1, 15, 16] ; however, the relationship between early surgical discharge and risk of post-discharge adverse events after RC has not been thoroughly explored. This topic is of great clinical and financial significance; within this context, we aimed to explore whether there was an association between early discharge after RC and post-discharge outcomes using a large validated national surgical database.
Materials and Methods

Data Source
The National Surgical Quality Improvement Program (NSQIP) Participant Use Data Files (PUFs) were queried for all patients who underwent RC between 2012 and 2015. We chose this time interval for several reasons. First, sample sizes of RC in 2005-2010 PUFs were limited and readmission data were not available. Although readmission data were reported in the 2011 PUF, there were significant changes in the reporting of readmission data in the 2012 PUF. Most notably, the cause of readmission and multiple readmission occurrences were available beginning with the 2012 PUF; therefore, to limit the heterogeneity of the raw data, our cohort was derived from the 2012 to 2015 PUFs.
The NSQIP database is maintained by the American College of Surgeons (ACS) and prospectively captures data in preoperative baseline patient characteristics, intra-operative variables and postoperative 30-day surgical outcomes. A detailed description of the NSQIP database (PUFs), including variable definitions, can be found at the ACS-NSQIP website and user guide file [17] . Institutional review board approval was not required, given this study used de-identified data.
Study Cohort and Study Design
The diagram for cohort selection and study design is shown in Fig. 1 . Patients who underwent RC for bladder cancer were selected based on Current Procedure Terminology (CPT) codes for 'complete' cystectomy (51570, 51575, 51580, 51585, 51590, 51595, 51596 and 51597) and International Classification of Disease (ICD)-9 codes (188.0-9, 233.7 and 239.4) or ICD-10 codes (C67.0-9, D09.0 and D49.4) for bladder cancer. Given our study objective, we applied the following exclusion criteria: patients with disseminated cancer; non-elective cases (including transferred patients); patients with pre-RC hospitalizations; and patients who died during the index (RC) hospitalization. We also excluded cases with an operating time (OT) of <120 min with the consideration of coding error, aborted surgery or benign diversion.
Consistent with one previous study, we only included patients who had an LOS of 4-9 days in the final cohort and categorized patients into an early-discharge group (LOS 4-5 days) and a routine-discharge group (LOS 6-9 days) [12] . We then excluded cases with missing data on some of the key study variables (Fig. 1) . Cases with missing data on race and diversion type were not excluded. The final cohort was generated after the selection process.
Co-variables
For each patient, age, sex, race, body mass index (BMI), American Society of Anesthesiologists (ASA) score, diversion type (based on CPT codes), wound classification, current smoking status, comorbidity score, OT, and discharge location were extracted and considered as co-variables. Comorbidity score was calculated based on a cumulative score of the following individual preoperative comorbidity conditions (one score for each condition) that were routinely collected in the 2012-2015 PUFs: diabetes; dyspnoea; dependent functional health status; ventilator dependence; chronic obstructive pulmonary disease; ascites; congestive heart failure; hypertension; acute renal failure; on dialysis; open wound; steroid usage; weight loss; bleeding disorder; transfusion, and systemic sepsis. The final comorbidity score was categorized into four groups: 0, 1, 2 and ≥3.
Outcomes of Interest
Primary outcomes of interest were the occurrence of readmission and occurrence of post-discharge complications ≤30 days after RC. In the NSQIP database, readmission is defined as an inpatient stay by the readmitting hospital or reported by the patient/family as such. Only a very small proportion of readmissions in our cohort were designated 'planned' (2/751, 0.27%), so 'any readmission' (to the same or another hospital for any reason) was used as a more sensitive measure in the present study.
Individual 30-day postoperative complications were designated as pre-discharge or post-discharge based on the time interval from RC to the event vs LOS. Then, individual pre-discharge and post-discharge complications were composited into the following: wound (superficial, deep and organ space surgical site infections, as well as wound dehiscence); pulmonary (pneumonia, reintubation and ventilator support >48 h); renal (acute renal failure and progressive renal insufficiency); cardiac (cardiac arrest and myocardial infarction); thromboembolic (deep vein thrombosis and pulmonary embolism); septic (sepsis and septic shock); and other (cerebrovascular accident, UTI, reoperation, and death). We considered transfusion as a separate entity given that it included both intra-operative and postoperative transfusion. Also, NSQIP does not provide data on intra-operative blood loss, and transfusion may serve as a proxy for blood loss.
Secondary outcomes of interest were the occurrence of any post-discharge adverse event and occurrence of a postdischarge major complication. A post-discharge adverse event
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© 2017 The Authors BJU International © 2017 BJU International was defined as readmission, any post-discharge complication, or post-discharge transfusion. The intent was to capture all adverse events after discharge. Post-discharge major complication was defined as any of the following: organ space surgical site infection; pneumonia; reintubation; ventilator support >48 h; acute renal failure; cardiac arrest; myocardial infarction; deep vein thrombosis; pulmonary embolism; sepsis; septic shock; cerebrovascular accident; reoperation or death. A diagram summarizing the definitions of primary and secondary outcomes of interest is shown in Fig. S1 .
Statistical Analysis
Baseline patient characteristics, peri-operative characteristics, and unadjusted outcomes were compared between earlydischarge and routine-discharge groups. Continuous variables (age, BMI, and OT) were transformed into categorical variables for analyses. Data were reported as frequencies (percentages) and compared using Fisher's exact test between the early-discharge group and routine-discharge group.
Multivariable logistic regression analyses, adjusted for the covariables (including pre-discharge transfusion and complication), were performed to assess the association of early discharge with readmissions, post-discharge complications, overall post-discharge adverse events, and post-discharge major complications.
Considering that the NSQIP counts 30-day outcomes starting from the day of surgery (instead of the day of discharge) and that longer LOS may be related to pre-discharge complications, we performed the sensitivity analysis including only patients with LOS of 4-7 days. After the first sensitivity analysis, we then excluded patients with any recorded 'predischarge adverse event (transfusion or any complication)' and performed a second sensitivity analysis to further explore the robustness of our primary analyses.
Finally, we performed subgroup analyses (univariable logistic regressions) to identify the associations between early discharge and primary outcomes in selected subsets of patients. Multivariable logistic regression analyses were not used because of limited number of occurrences of some covariables and/or outcomes in some subgroups. We then repeated the subgroup analyses in the previously described 'sensitivity analyses' cohorts. Subgroups were determined based on the differences in baseline patient and peri-operative characteristics between the early-discharge and routinedischarge groups (age, sex, race, diversion type, OT and discharge location).
All tests were two-sided and P values <0.05 were taken to indicate statistical significance. All analyses were performed using STATA 14 (StataCorp LP, College Station, TX, USA).
Results
Patient and Peri-operative Characteristics
A total of 3 311 patients were included in this study (Fig. 1) . Baseline patient and peri-operative characteristics are shown in Table 1 . Overall, patients in the early-discharge group were younger (P = 0.028) and more frequently male (P < 0.001). They had a shorter OT (P < 0.001), more frequently had non-continent diversions, and were more likely to be discharged to home (P < 0.001). There was no significant difference in comorbidity score (P = 0.690) or ASA score (P = 0.203) between the early-discharge and the routinedischarge group. Individual comorbidities are shown in Table 1 Baseline characteristics of the final included cohort, stratified by early discharge (length of hospital stay [LOS] = 4-5 days) vs routine discharge (LOS = 6-9 days). Table S1 . There was no significant difference in any of the individual comorbidities between the two groups.
Pre-discharge Adverse Events
Pre-discharge adverse events are summarized in Table 2 .
Compared with the routine-discharge group, patients in the early-discharge group had lower rates of pre-discharge complications (2.6% vs 6.4%; P < 0.001), transfusions (29.1% vs 39.5%; P < 0.001), overall adverse events (30.7% vs 42.5%; P < 0.001), and major complications (0.6% vs 3.7%; P < 0.001). Also, fewer patients in the early-discharge group had multiple (≥2) pre-discharge complications (0.1% vs 0.8%; P < 0.001). Individual and composite pre-discharge complications are shown in Table S2 . Patients in the earlydischarge group had fewer pre-discharge unplanned intubations (0% vs 0.6%; P = 0.028), pulmonary complications (0% vs 1.0%; P = 0.001), renal complications (0.1% vs 1.0%; P = 0.017), thromboembolic complications (0.1% vs 0.8%; P = 0.039), and reoperations (0% vs 0.7%; P = 0.019).
Unadjusted Outcomes
Unadjusted outcomes of interest are summarized in Table 2 .
There was no significant difference in readmission rate (21.6% vs 23.0%; P = 0.412), post-discharge complication rate (17.7% vs 19.6%; P = 0.237), overall post-discharge adverse event rate (26.8% vs 27.4%; P = 0.785), or post-discharge major complication rate (11.2% vs 13.9%; P = 0.056) between the early-discharge and the routine-discharge group. Also, there was no significant difference in the number of patients who had multiple (≥2) readmissions (1.4% vs 2.0%; P = 0.482) or post-discharge complications (8.5% vs 8.3%; P = 0.233). Individual and composite post-discharge complications are shown in Table S2 . There was no significant difference in any of the individual or composite post-discharge complication rates between the two groups.
Outcomes of interest grouped by LOS are shown in Fig. 2 . In the early-discharge group (LOS 4-5 days), patients with an LOS of 4 days had higher rates of all outcomes of interest. In the routinedischarge group (LOS 6-9 days), patients with an LOS of 6 days had the lowest rates of all outcomes of interest; however, there was no significant difference in any of the outcomes between an LOS of 4 days and an LOS of 6 days (Fig. 2) .
Multivariate Logistic Regression Models
Multivariable logistic regression analyses for readmission, postdischarge complication, post-discharge adverse event and postdischarge major complication in the overall cohort (n = 3 311) are shown in Fig. 3 (full model in Table S3 ). The results revealed that early discharge was not associated with increased odds of readmission (odds ratio [OR] 1.00, 95% CI 0.82-1.22; P = 1.000), post-discharge complications (OR 0.95, 95% CI 0.77-1.17; P = 0.616), post-discharge adverse events (OR 1.07, 95% CI 0.88-1.26; P = 0.505), or post-discharge major complications (OR 0.85, 95% CI 0.66-1.10; P = 0.213); however, higher BMI, higher comorbidity score, continent diversion and longer OT were consistently associated with increased odds of readmission, post-discharge complications, overall post-discharge adverse events, and post-discharge major complications. In addition, having a pre-discharge complication was associated with increased odds of readmission, overall post-discharge adverse events, and postdischarge major complications. Table 2 Pre-discharge and post-discharge adverse events, stratified by early discharge (length of hospital stay [LOS] = 4-5 days) vs routine discharge (LOS = 6-9 days).
Postoperative adverse events Pre-discharge occurrences Post-discharge occurrences 
Sensitivity Analyses
Sensitivity analyses (n = 2 457) in patients with LOS of 4-7 days are shown in Fig. 3 (full model in Table S4 ). Early discharge was still not associated with increased odds of readmission (OR 1.05, 95% CI 0.85-1.29; P = 0.666), postdischarge complications (OR 1.00, 95% CI 0.80-2.25; P = 0.993), post-discharge adverse event (OR 1.10, 95% CI 0.91-1.35; P = 0.317), or post-discharge major complication (OR 0.89, 95% CI 0.68-1.16; P = 0.380).
Sensitivity analyses (n = 1 555) in patients with an LOS of 4-7 days and without pre-discharge adverse events are shown in Table S5 ). Early discharge was still not associated with increased odds of readmission (OR 1.04, 95% CI 0.80-1.36; P = 0.754), post-discharge complications (OR 1.05, 95% CI 0.79-1.39; P = 0.729), post-discharge adverse events (OR 1.05, 95% CI 0.82-1.34; P = 0.724), or postdischarge major complications (OR 0.99, 95% CI 0.71-1.38; P = 0.968).
Subgroup Analyses
Subgroup analyses results are shown in Fig. 4 . Early discharge was not associated with increased odds of readmission in all subsets of patients except the subgroup of age ≥85 years in 
P=0.723
Percentage of patients 
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Discussion
To our knowledge, this is the first national hospital-based study and the largest study to date comparing post-discharge outcomes between early discharge and routine discharge after RC. Our analyses show that early discharge was not associated with increased risk of 30-day readmissions or postdischarge complication. More specifically, it may be safe to discharge a significant number of patients on postoperative day 4 or day 5 without compromising post-discharge outcomes.
The findings of the present study are concordant with previous studies in other surgical fields. Recent evidence suggests that early discharge after colorectal cancer surgery is safe in terms of readmissions [6] [7] [8] . Hendren et al. [6] studied 477 461 patients who underwent colectomy for cancer in the national Medicare database and showed that hospitals with a pattern of early discharge (median LOS ≤5 days after surgery) did not have a higher risk-adjusted 30-day readmission rate. Hoffman et al. [7] also concluded that early discharge after colorectal surgery may be implemented without any adverse effect on readmission rates based on the analyses of NSQIP data. The majority of studies on other types of surgery, such as joint arthroplasty, bariatric surgery, lobectomy and aortic valve replacement has also shown no detrimental effects from early discharge [9] [10] [11] 18] . The present study adds to the evidence supporting the hypothesis that early hospital discharge and post-discharge outcomes are compatible, even for a morbid oncological surgery such as RC.
Osawa et al. [12] recently reported a retrospective, singleinstitutional study that compared outcomes between earlydischarge and routine-discharge after RC. A total of 484 consecutive patients with LOS of 4-9 days were included in the study and the results showed that early discharge (LOS ≤5 days) after RC was associated with an increased risk of 90-day major outpatient complications and readmissions. The discrepancy between the present study and that of Osawa et al. [12] could be related to several factors. First, a , may have limited the statistical power of their study. Second, and more importantly, only patients who underwent RC before the adoption of enhanced recovery after surgery (ERAS) peri-operative care programmes were included in their study, whereas the present study used a more contemporary (2012-2015) study cohort from a nationally representative database. Although NSQIP does not provide information on peri-operative care, it is possible on an institutional level that some patients in our study cohort may have participated in an ERAS protocol. Recent evidence has shown that ERAS can safely reduce LOS without compromising patient outcomes in major abdominal surgeries, including RC [15, 16] .
The NSQIP only provides postoperative 30-day follow-up and there are two obvious concerns regarding this time window. Counting 30-day outcomes starting from the day of surgery instead of the day of discharge inherently causes the earlydischarge group to have longer follow-up time than the routine-discharge group. We tried to mitigate this issue by excluding LOS of 8-9 days in the sensitivity analyses. In addition, if we could extend the follow-up time for the routine-discharge group, we would expect to capture more adverse events, thus further supporting our conclusion. Another concern is that 30-day follow-up may not be long enough to capture all the adverse events after RC; however, the overall readmission rate of 22.7% in the present study is consistent with previously reported 30-day readmission rates [13, 14] . Previous studies have shown that major complications and readmissions mainly occur within the first 30 days after surgery [13, 14, 19] . Also, complications usually decline in both number and severity over time [19] ; therefore, it is reasonable to assume that patients in the early-discharge group in the present study were unlikely to have significantly more complications or readmissions after 30 days of RC compared with patients in the routine-discharge group, especially when considering our cohort represented a subset of patients with fewer inpatient complications (LOS 4-9 days).
Aside from in a very small subgroup of patients aged ≥85 years, we did not find any association between earlydischarge and post-discharge adverse outcomes; however, several risk factors for readmissions and post-discharge complications were identified. These risk factors may be considered relevant when selecting patients for early discharge, which might be a more important question on this topic. Patients with a normal BMI, lower comorbidity score, non-continent diversion, and shorter OT may be more suitable for early discharge. Another significant risk factor for readmission was pre-discharge complication, and the earlydischarge group had fewer pre-discharge complications. With all findings considered, the present study also suggests that appropriately selecting patients for accelerated discharge may be a metric of high-quality surgical care, and urologists from NSQIP hospitals have been successful in identifying those who could be discharged earlier after RC.
While a reduced LOS appears to be safe, it is important to note that this probably occurs as a byproduct of widespread institutional support, improved patient education, and evidence-based care pathways to minimize variation in the delivery of care. As part of a broader initiative to improve the quality of care, we expect the ratio of early to routine discharge LOS to shift over time. In the present study cohort, 57.5% of patients in the routine-discharge group had none of the defined adverse events (transfusion and complication) before discharge. Although it is possible that some patients experienced relevant events (e.g. delayed recovery of bowel function) that delayed discharge but did not meet the criteria for NSQIP complications, it is also likely that some patients stayed longer simply because of practice style differences among hospitals and physicians [20] . Efforts to reduce waste of resources and increase care efficiency can focus on this group of patients.
The present study has some limitations, most of which are related to the features of the NSQIP database. First, the NSQIP lacks information on LOS during readmission. The severity of complications leading to readmission measured by LOS may differ among patients who had readmissions after RC [19] . Second, the lack of data on patient socioeconomic status, travel distance, and hospital type (academic vs community) may have had an impact on the likelihood of capturing readmission data. Third, it is not possible to fully and accurately identify those who underwent laparoscopic and robot-assisted RCs in the NSQIP because they do not have separate CPT codes; thus, inherent differences in approach between the groups could not be explored. Fourth, cancer stage is not available in the database and could not be included in our analysis; this could have provided additional information. Finally, our study cohort came from hospitals with a presumed interest in surgical quality improvement in the USA, so our results may not be generalizable to all hospitals and other countries.
In conclusion, early discharge after RC was not associated with readmissions or post-discharge complications. Future prospective studies, with defined peri-operative care pathways, are needed to identify potential components that may enable hospitals to discharge patients early without compromising post-discharge outcomes.
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Supporting Information
Additional Supporting Information may be found in the online version of this article: Figure S1 . Diagram summarizing the definitions of primary and secondary outcomes of interest. Table S1 . Individual patient comorbidities in the overall cohort, stratified by early discharge (LOS = 4-5 days) vs routine discharge (LOS = 6-9 days). Table S2 . Pre-discharge and post-discharge individual and composite complications, stratified by early discharge (LOS = 4-5 days) vs routine discharge (LOS = 6-9 days). Table S3 . Multivariable logistic regression models in the overall cohort (n = 3 311). Table S4 . Sensitivity analyses (logistic regressions) in patients with LOS of 4-7 days (n = 2 457). Table S5 . Sensitivity analyses (logistic regressions) in patients with LOS of 4-7 days and without any pre-discharge adverse events (n = 1 555).
